4//SEC Filing
Woodworth Emily 4
Accession 0001225208-25-002992
CIK 0000885725other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:16 PM ET
Size
10.3 KB
Accession
0001225208-25-002992
Insider Transaction Report
Form 4
Woodworth Emily
SVP, Global Controller and CAO
Transactions
- Exercise/Conversion
Common Stock
2025-03-03$37.50/sh+5,949$223,088→ 8,063 total - Sale
Common Stock
2025-03-03$104.97/sh−7,149$750,465→ 914 total - Sale
Common Stock
2025-03-04$104.63/sh−482$50,432→ 432 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-03−5,949→ 2,383 totalExercise: $37.50Exp: 2031-02-17→ Common Stock (5,949 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on November 29, 2024.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.85 to $105.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0002013518
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:16 PM ET
- Size
- 10.3 KB